Comparative Benchmarking
In the context of the broader market, ZNTL competes directly with industry leaders such as ALEC and IPSC. With a market capitalization of $160.26M, it holds a significant position in the sector. When comparing efficiency, ZNTL's gross margin of N/A stands against ALEC's 100.00% and IPSC's 100.00%. Such benchmarking helps identify whether Zentalis Pharmaceuticals Inc is trading at a premium or discount relative to its financial performance.
